{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:55:31Z","timestamp":1772751331306,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.3816\/clm.2006.n.053","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:11:10Z","timestamp":1221095470000},"page":"145-147","source":"Crossref","is-referenced-by-count":40,"title":["Scleritis Complicating Zoledronic Acid Infusion"],"prefix":"10.3816","volume":"7","author":[{"given":"David","family":"Benderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyson","family":"Karakunnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajeev","family":"Kathuria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Badros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2006.n.053_bib1","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.053_bib2","first-page":"115","article-title":"Pharmacological actions and pharmacokinetics of bisphosphonates","volume":"13","author":"Takeyama","year":"2003","journal-title":"Clin Calcium"},{"key":"10.3816\/CLM.2006.n.053_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2165\/00002018-199614030-00003","article-title":"Adverse effects of bisphosphonates. A comparative review","volume":"14","author":"Adami","year":"1996","journal-title":"Drug Saf"},{"key":"10.3816\/CLM.2006.n.053_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2006.n.053_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0140-6736(93)93029-Z","article-title":"Bisphosphonates and iritis","volume":"341","author":"Siris","year":"1993","journal-title":"Lancet"},{"key":"10.3816\/CLM.2006.n.053_bib6","first-page":"422","article-title":"Bisphosphonates and ocular disorders","volume":"50","author":"Adverse drug reactions in Canada","year":"2004","journal-title":"Can Fam Physician"},{"key":"10.3816\/CLM.2006.n.053_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2006.n.053_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(14)72902-2","article-title":"Pamidronate disodium and possible ocular adverse drug reactions","volume":"118","author":"Macarol","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.3816\/CLM.2006.n.053_bib9","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2003.01.055","article-title":"DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma","volume":"21","author":"Lee","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.053_bib10","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.3816\/CLM.2006.n.053_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.3816\/CLM.2006.n.053_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1742-1241.1995.tb09976.x","article-title":"Paget's disease: ocular complications of disodium pamidronate treatment","volume":"49","author":"O'Donnell","year":"1995","journal-title":"Br J Clin Pract"},{"key":"10.3816\/CLM.2006.n.053_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.SMJ.0000152753.80490.9F","article-title":"Bisphosphonate-associated scleritis: a case report and review","volume":"98","author":"Leung","year":"2005","journal-title":"South Med J"},{"key":"10.3816\/CLM.2006.n.053_bib14","first-page":"71","article-title":"Posterior uveitis: an underrecognized adverse effect of pamidronate: 2 case reports","author":"Haverbeke","year":"2003","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.3816\/CLM.2006.n.053_bib15","first-page":"179","article-title":"Diphosphonates: ocular risks","volume":"14","year":"2005","journal-title":"Prescrire Int"},{"key":"10.3816\/CLM.2006.n.053_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9394(02)01840-8","article-title":"Scleritis and other ocular side effects associated with pamidronate disodium","volume":"135","author":"Fraunfelder","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.3816\/CLM.2006.n.053_bib17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0025-7753(02)72464-0","article-title":"Episcleritis secondary to risedronate","volume":"118","author":"Vinas","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.3816\/CLM.2006.n.053_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ophtha.2003.12.052","article-title":"Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects","volume":"111","author":"Fraunfelder","year":"2004","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2006.n.053_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2005.02665.x","article-title":"The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins","volume":"139","author":"Hewitt","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.3816\/CLM.2006.n.053_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","article-title":"Scleral structure, organisation and disease. A review","volume":"78","author":"Watson","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.3816\/CLM.2006.n.053_bib21","first-page":"46","article-title":"Inflammatory cellular infiltration in scleritis","volume":"92","author":"Bernauer","year":"1995","journal-title":"Ophthalmologe"},{"key":"10.3816\/CLM.2006.n.053_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s003470050098","article-title":"Autoantibody pattern in scleritis and episcleritis","volume":"94","author":"Zierhut","year":"1997","journal-title":"Ophthalmologe"},{"key":"10.3816\/CLM.2006.n.053_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.053_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.leu.2403693","article-title":"Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma","volume":"19","author":"Mariani","year":"2005","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2006.n.053_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2000.15.1.147","article-title":"Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations","volume":"15","author":"Pecherstorfer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CLM.2006.n.053_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","article-title":"Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines","volume":"174","author":"Conti","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2006.n.053_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20987","article-title":"Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy","volume":"116","author":"Sato","year":"2005","journal-title":"Int J Cancer"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:35:40Z","timestamp":1709231740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011703171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1557919011703171"],"URL":"https:\/\/doi.org\/10.3816\/clm.2006.n.053","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}